ISRG vs XOM: Which Is the Better Buy?
Side-by-side comparison of Intuitive Surgical, Inc. and Exxon Mobil Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-16.
Intuitive Surgical, Inc. · Healthcare
$388.97
+45.0% upside to fair value
Grade B
High Quality
VS
Exxon Mobil Corporation · Energy
$137.81
-45.0% upside to fair value
Grade C
QuantHub Verdict
ISRG has more upside to fair value
(+45.0%).
XOM trades at a lower forward P/E
(22.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ISRG |
XOM |
| Current Price |
$388.97 |
$137.81 |
| Fair Value Estimate |
$564.01 |
$75.80 |
| Upside to Fair Value |
+45.0%
|
-45.0%
|
| Market Cap |
$137.8B |
$571.2B |
| Forward P/E |
46.5x
|
22.8x
|
| EV / EBITDA |
31.4x
|
10.1x
|
| Price / Sales |
13.0x
|
1.8x
|
| Price / FCF |
48.6x
|
30.4x
|
| Revenue Growth YoY |
+23.0%
|
+2.6%
|
| Gross Margin |
66.3%
|
25.5%
|
| Operating Margin |
30.5%
|
9.0%
|
| Return on Equity |
17.0%
|
9.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.06%
|
3.29%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Intuitive Surgical, Inc. operates in the healthcare sector, specializing in medical devices with a strong focus on robotic-assisted surgery systems. The company demonstrates high business quality with a durable competitive moat supported by a 17.0% return on equity, robust gross margin of 66.3%, and solid operating margin of 30.5%. Revenue and earnings growth in the most recent quarter were impre…
Exxon Mobil Corporation is a leading integrated oil and gas company with a durable competitive moat based on its scale, integration, advantaged long-life resources, proprietary technology, and irreplaceable infrastructure. The company is led by a long-tenured management team with a strong capital allocation track record focused on dividends and buybacks. Despite these strengths, Exxon is currentl…
Accumulation Zones
| Metric |
ISRG |
XOM |
| Zone Low |
$423.01 |
$56.85 |
| Zone High |
$479.41 |
$64.43 |
| In Buy Zone? |
Yes
|
No
|